EARLY CLINICAL-STUDY OF AN INTERMITTENT SCHEDULE FOR MAYTANSINE (NSC-153858)

被引:30
作者
EAGAN, RT
INGLE, JN
RUBIN, J
FRYTAK, S
MOERTEL, CG
机构
关键词
D O I
10.1093/jnci/60.1.93
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:93 / 96
页数:4
相关论文
共 5 条
[1]  
GOLDSMITH MA, 1975, CANCER RES, V35, P1354
[2]  
HOLMAN LJ, 1976, CLINICAL BROCHURE MA
[3]   TUMOR INHIBITORS .73. MAYTANSINE, A NOVEL ANTILEUKEMIC ANSA MACROLIDE FROM MAYTENUS-OVATUS [J].
KUPCHAN, SM ;
KOMODA, Y ;
THOMAS, GJ ;
SMITH, RM ;
BRYAN, RF ;
HALTIWAN.RC ;
KARIM, A ;
COURT, WA ;
GILMORE, CJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (04) :1354-+
[4]   ANTIMITOTIC ACTIVITY OF POTENT TUMOR INHIBITOR MAYTANSINE [J].
REMILLARD, S ;
REBHUN, LI ;
HOWIE, GA ;
KUPCHAN, SM .
SCIENCE, 1975, 189 (4207) :1002-1005
[5]   INITIAL STUDIES ON MAYTANSINE-INDUCED METAPHASE ARREST IN L1210 MURINE LEUKEMIA-CELLS [J].
WOLPERTDEFILIPPES, MK ;
BONO, VH ;
DION, RL ;
JOHNS, DG .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (18) :1735-1738